Experimentelle Therapieoptionen bei fortgeschrittener Zirrhose und ACLF

This publication has 32 references indexed in Scilit:

• Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality
  JAMA Network Open, 2023
• Design of a multicenter randomized clinical trial for treatment of Alcohol-Associated Hepatitis
  Contemporary Clinical Trials Communications, 2023
• IL‐1 receptor antagonist plus pentoxifylline and zinc for severe alcohol‐associated hepatitis
  Hepatology, 2022
• Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial
  Hepatology International, 2022
• Programmed Death Ligand 1 Is Overexpressed in Liver Macrophages in Chronic Liver Diseases, and Its Blockade Improves the Antibacterial Activity Against Infections
  Hepatology, 2020
• An Open‐Label, Dose‐Escalation Study to Assess the Safety and Efficacy of IL‐22 Agonist F‐652 in Patients With Alcohol‐associated Hepatitis
  Hepatology, 2020
• Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo‐Controlled Trial
  Hepatology, 2019
• IL‐22 and IL‐22‐Binding Protein Are Associated With Development of and Mortality From Acute‐on‐Chronic Liver Failure
  Hepatology Communications, 2019
• Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury
  JAMA, 2018
• Allogeneic bone marrow–derived mesenchymal stromal cells for hepatitis B virus–related acute‐on‐chronic liver failure: A randomized controlled trial
  Hepatology, 2017